Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event

Go back to Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
(NASDAQ: AUTL) Delayed: 1.86 -0.05 (2.62%)
Previous Close $1.91    52 Week High $ 
Open $1.91    52 Week Low $ 
Day High $1.95    P/E N/A 
Day Low $1.85    EPS $ 
Volume 1,383,523